Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Ciesek

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
The Lancet. Infectious Diseases|February 2, 2023
Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?Sebastian Hoehl, Sandra Ciesek
Methods in Molecular Biology (Clifton, N.J.)|December 30, 2018
Expression Cloning of Host Factors Required for the HCV Replication CycleSandra Ciesek, Thomas von Hahn
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Hepatitis in 2010: the dawn of a new era in HCV therapySandra Ciesek, Michael P Manns
Current Opinion in Virology|August 18, 2015
Cyclophilin polymorphism and virus infectionThomas von Hahn, Sandra Ciesek
Advances in Experimental Medicine and Biology|May 11, 2021
Pediatrics and COVID-19Tuna Toptan, Sandra Ciesek, Sebastian Hoehl
Discovery Medicine|September 30, 2011
Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factorsThomas von Hahn, Sandra Ciesek, Michael P Manns
Vaccine|June 15, 2021
A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinatedSebastian Hoehl, Sandra Ciesek, Jürgen Graf, et al.
Clinics in Liver Disease|August 27, 2011
Second-wave protease inhibitors: choosing an heirSandra Ciesek, Thomas von Hahn, Michael P Manns
Expert Review of Gastroenterology & Hepatology|February 9, 2010
Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approachesThomas von Hahn, Eike Steinmann, Sandra Ciesek, et al.
Journal of Hepatology|January 13, 2019
Influenza virus infection as precipitating event of acute-on-chronic liver failureAndreas Schütte, Sandra Ciesek, Heiner Wedemeyer, et al.
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
The Lancet. Infectious Diseases|February 2, 2023
Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?Sebastian Hoehl, Sandra Ciesek
Methods in Molecular Biology (Clifton, N.J.)|December 30, 2018
Expression Cloning of Host Factors Required for the HCV Replication CycleSandra Ciesek, Thomas von Hahn
Nature Reviews. Gastroenterology & Hepatology|February 5, 2011
Hepatitis in 2010: the dawn of a new era in HCV therapySandra Ciesek, Michael P Manns
Current Opinion in Virology|August 18, 2015
Cyclophilin polymorphism and virus infectionThomas von Hahn, Sandra Ciesek
Advances in Experimental Medicine and Biology|May 11, 2021
Pediatrics and COVID-19Tuna Toptan, Sandra Ciesek, Sebastian Hoehl
Discovery Medicine|September 30, 2011
Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factorsThomas von Hahn, Sandra Ciesek, Michael P Manns
Vaccine|June 15, 2021
A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinatedSebastian Hoehl, Sandra Ciesek, Jürgen Graf, et al.
Clinics in Liver Disease|August 27, 2011
Second-wave protease inhibitors: choosing an heirSandra Ciesek, Thomas von Hahn, Michael P Manns
Expert Review of Gastroenterology & Hepatology|February 9, 2010
Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approachesThomas von Hahn, Eike Steinmann, Sandra Ciesek, et al.
Journal of Hepatology|January 13, 2019
Influenza virus infection as precipitating event of acute-on-chronic liver failureAndreas Schütte, Sandra Ciesek, Heiner Wedemeyer, et al.
Pageof 23